PY74, Pigment Yellow 74; PY74-M1 metabolite of PY74; PY74-M2 metabolite of PY74; MSDS, material safety data sheet; BSA, bovine serum albumin; 3-MC, 3-methylcholanthrene; DMSO, dimethylsulfoxide; PB, phenobarbital.
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INTRODUCTION
Pigment Yellow 74 (Figure 1 ) is a monoazo-based pigment that is manufactured under a variety of trade names and formulations for various industrial applications including coatings, offset inks, dry toner, liquid inks, and paint finishes. PY74 and other monoazo pigments are not manufactured for consumption or direct dermal application in humans, and are not listed as an approved color additive for use in foods, drugs, cosmetics or medical devices.
PY74 is included in tattoo inks and permanent makeup that are available in
Europe (Lehmann and Pierchalla, 1988; Danish Environmental Protection Agency, 2003; Bäumler et al., 2000 Bäumler et al., , 2004 Papameletiou et al., 2003) and in the United States (Cui et al., 2004) .
Tattooing is an ancient art form where colored materials are inserted into the skin with a sharp object. Recently, social/cultural trends in the US and other developed countries have resulted in a surge in the popularity of tattooing.
Tattooing has been used recently as a permanent means to cover unwanted skin discoloration (e.g. vitiligo) or disfiguration (Mazza and Rager, 1993) or to correct skin color following some surgeries (Price et al., 2000) ; however, the single largest reason for voluntarily obtaining a tattoo has been personal artistic expression. In addition, permanent coloration of the lips and eyelids through tattooing is increasing in popularity and includes the application of black iron oxides and colored tattoo inks.
Tattooing has been identified as a significant risk factor for contraction of bacterial or viral (hepatitis and human immunodeficiency syndrome; HIV-AIDS)
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5 infections (Long and Rickman, 1994; Haley and Fischer, 2001; Hayes and Harkness, 2001; Hellard et al., 2004) . In addition to infectious diseases, other risks associated with tattooing (reviewed in Papameletiou et al., 2003) have included acute phototoxicity, granulomateous and lichenoid reactions, development of pseudo-lymphomas, immunological-based rejection of the tattoo, and unwanted pigment spreading or inconsistencies within the tattoo. There have been reports of non-melanoma skin cancer arising within tattoos (Weiner and Scher, 1987; McQuarrie, 1996; Jacob, 2002) ; however, these observations have not been substantiated by epidemiological studies.
The earliest tattoos were most likely derived from soot or charcoal with occasional inclusion of locally available minerals or plant products. In more recent times, inorganic compounds, such as titanium dioxide, mercuric oxide and cadmium sulfide, have been used in tattoo inks (Lehmann and Pierchalla, 1988) .
The demand for an increasing number of color shades and color intensity by customers and reports of toxicity of some of the inorganic salts has led tattoo ink manufacturers to replace the inorganic salts with organic pigments to achieve the desired colors and eliminate the toxicity associated with certain metal salts. Lehmann and Pierchalla (1988) and Bäumler et al. (2000) have listed many of these pigments, which include yellow, orange, blue, green, and red pigments commonly used in the paint and commercial printing industries. Little or no toxicity data have been reported for many of these pigments, even though they contain structural alerts for mutagenicity and/or carcinogenicity.
This article has not been copyedited and formatted. The final version may differ from this version. Liver microsomes from male F344 rats pretreated with 3MC (intraperitoneal administration in corn oil for 3 consecutive days, 25 mg/kg body weight/day) were prepared by a standard procedure in our lab (Howard et al., 1988) . The microsomal pellets were suspended in 250 mM sucrose, 50 mM potassium phosphate, pH 7.4, at approximately 20 mg/mL and stored at -80 o C .
Protein content was determined using the method of Lowry et al. (1951) . The total cytochrome P450 (CYP) content was calculated using the extinction coefficient 9.1x10 4 M -1 cm -1 from the difference spectrum of sodium dithionitereduced and CO-saturated P450 according to the method of Johannesen and DePierre (1978) . Human liver microsomes or male Sprague-Dawley rat liver microsomes from either untreated or phenobarbital (PB) pretreated rats were 
Microsomal Incubations
The PY74 stock solution was prepared immediately before the assay by mixing 0.4 mL of 1.3 mM PY74 in DMSO with 10 mL water containing 10 mg/mL bovine serum albumin. The co-enzyme stock solution contained 2 mM NADP, 1.5 mM NADH, 20 mM glucose-6-phosphate, 2 units/mL glucose-6-phosphate dehydrogenase, 10 mM MgCl 2 , and 100 mM potassium phosphate, pH 7.4.
Immediately prior to use, 1 mg/mL microsomal protein was added. Equal amounts (250 µL) of the two solutions were mixed at 37 o C to start the reaction. In the experiments to determine the specificity of human P450 isozymes in the metabolism of PY74, the incubations contained final concentrations of 0.25 nmol P450/mL, 1 mM NADP, 800 µM NADH, 10 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase, 4 mM MgCl 2 , 10 mg/mL BSA, 50 mM potassium phosphate, pH 7.4, and 25 µM PY74 (or the metabolite PY74- The extraction and HPLC analysis were the same as described above for microsomal metabolism of PY74.
High Performance Liquid Chromatography (HPLC)
HPLC analyses were carried out using a Waters liquid chromatography Figure 2 ).
Liquid Chromatography-Mass Spectrometry
The HPLC separation coupled with mass spectrometry was performed with a column and mobile phase that differed from the conditions used in the analytical studies. The solid phase was a Luna C 18 column (2.1 x 150 mm, 3 An AD20 UV detector (Dionex, Sunnyvale, CA) was installed between the column and mass spectrometer and the UV absorption of the column eluate was monitored at 254 nm. For direct infusion studies, the sample was delivered at approximately 10 µL/ min using a syringe pump (KDS-100, KD Scientific Co., Boston, MA) into a tee with 200 µL/min of the initial gradient mobile phase as make-up flow before entering the mass spectrometer.
Mass spectra (MS/MS) were acquired on a Quattro Ultima triple quadrupole mass spectrometer (Waters Corp., Manchester, U.K.) equipped with an atmospheric pressure chemical ionization (APCI) interface (heated nebulizer probe at 400°C) and an ion source temperature of 120°C. Negative ion product spectra were acquired using a collision gas cell pressure (argon) of 1.8 x 10
-3
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11 mbar and various collision energies, with a cone voltage of 40V. The corona pin was set at 20 µ A and nitrogen was used as the cone gas and desolvation gas at 101 L/hr respectively.
Metabolite Isolation for NMR
All metabolites for NMR characterization were isolated from a 200 mL incubation using 500 µg/mL 3MC-induced rat liver microsomal protein, 1 mM NADP, 800 µM NADH, 10 mM glucose-6-phosphate, 1 unit/mL glucose-6-phosphate dehydrogenase, 4 mM MgCl 2 , 25 µM PY74, and 10 mg/mL bovine serum albumin in 50 mM potassium phosphate, pH 7.4. After 1 hour, the solution was extracted with 400 mL of CH 2 Cl 2 :MeOH (2:1), then 2 times with 200 mL CH 2 Cl 2 . The organic phases were combined, dehydrated using anhydrous Na 2 SO 4 , then concentrated to 5-10 mL using evaporation under reduced pressure (Rotavapor-011, Büchi Labortechnik AG, Flawil, Swizerland). The products in the extract were separated using a 4.5 x 10 cm column of 60 Å (230-400 mesh) silica gel (Merck, Sigma-Aldrich). PY74 and a metabolite (PY74-M1)
were eluted separately using CH 2 Cl 2 . A second metabolite (PY74-M2) was eluted from the column using a mobile phase of CH 2 Cl 2 :methanol (98:2).
The metabolite PY74-M1 was further purified using HPLC consisting of a Varian 9012 solvent delivery system (Varian, Walnut Creek, CA, USA) and a Luna C 18 column (4.6 x 150 mm, 3 µm particle; Phenomenex). The isocratic mobile phase consisted of water:methanol:acetonitrile (30:35:35) with a flow rate of 1.0 mL/min. UV absorbance of the eluate was monitored at 254 nm using a
NMR Spectroscopy
Proton NMR spectra were obtained at 500 MHz on a Bruker AM-500
spectrometer ( 
RESULTS
Microsomal Metabolism of PY74
PY74 was incubated with rat liver microsomal protein from 3MC-induced male F344 rat liver to determine if PY74 could be metabolized. As shown in PY74 has poor solubility in water. The solubility of PY74 in the microsomal incubations was increased by the inclusion of BSA. The metabolism of PY74 by 3MC-induced microsomes plateaued between 5-10 mg/mL BSA (results not shown), and therefore we used 5 mg/mL BSA in subsequent studies.
The metabolic activity increased significantly when the concentration of microsomal protein was increased from 100 µg/mL to 500 µg/mL, plateauing at 500 µg/mL with no additional increase in metabolism at 1 mg/mL (data not shown). The dependence of PY74 metabolism on PY74 concentration indicated a linear dependence of metabolism on the concentration of PY74 plateauing at 50 µM. Our initial intent was to conduct zero-order studies to understand the kinetics of PY74 metabolism; however, no kinetic analyses were conducted because of the complexity of the analysis (i.e. dependent on combined K d of PY74 from BSA directly into microsomal lipid, PY74 solubility in microsomal lipid, solubility of PY74 in aqueous solution, and K m and V max properties of the CYP).
This article has not been copyedited and formatted. The final version may differ from this version. C labeled), we assumed that the molar extinction coefficients for PY74, PY74-M1, and PY74-M2 were equal. As a result, the HPLC eluate was monitored at 420 nm and the peak areas of all eluting compounds were quantified. The formation of PY74-M1 and PY74-M2 paralleled the loss of PY74, with a greater accumulation of PY74-M1 than PY74-M2.
Identification of Microsomal Metabolites
This article has not been copyedited and formatted. The final version may differ from this version. The two microsomal metabolites of PY74 (i.e. PY74-M1 and PY74-M2)
were generated and purified as described in Materials and Methods. PY74-M1
was analyzed using HPLC coupled with negative ion APCI mass spectrometry. The NMR spectrum of PY74-M1 was obtained and compared to the previously assigned spectrum of PY74 (Cui et al., 2004) . Examination of the spectrum (not shown) for PY74-M1 revealed that all proton resonances from PY74 are present with the exception of the H4" proton at 7.13 ppm ( Table 1) .
PY74-
The resonance for proton H3" in PY74-M1 is shifted upfield by 0.46 ppm as compared to H3" in PY74 suggesting hydroxyl substitution at an adjacent (ortho)
carbon. H3" in PY74-M1 has only a long-range meta-coupling of 2.7 Hz to H5", whereas, H3" in PY74 has predominantly an ortho coupling of 8.1 Hz to H4", and meta coupling to H5". Similarly, the resonance for proton H5" in PY74-M1 is shifted upfield by 0.56 ppm when compared to H5" in PY74 suggesting hydroxyl which is meta to the C7' hydroxyl. Thus, the structure of PY74-M2 was identified as 2-((2-hydroxy-4-nitrophenyl)azo)-N-(2-methoxy-4-hydroxyphenyl)-3-oxobutanamide. This metabolite is not stable in water at room temperature and decomposes to more polar compounds.
Metabolism of PY74 and PY74-M1 by Human Cytochromes P450
The incubation of PY74 with human liver microsomes (not shown) resulted in the formation of predominantly PY74-M1 and PY74-M2, with one minor peak that was less polar than PY74-M1 which was not identified due to lack of sufficient material. The specificity of the human CYP metabolism of PY74 is shown in Figure 5 , where CYP 1A2 had the highest activity followed by CYPs 
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18 DISCUSSION This is the first report describing the metabolism of PY74 by microsomal proteins or cytochromes P450 and the specificity of the site of metabolism (Figure 7) . This work is of public health significance because many individuals are being tattooed with this pigment as color component of some yellow tattoo inks (Lehmann and Pierchalla, 1988; Bäumler et al., 2000; Cui et al., 2004) . To date, neither the metabolism of PY74 nor the description of the identity of any metabolites of PY74 has been presented.
We find that PY74 is metabolized by microsomal protein from 3MC-induced rat livers. 3MC is an inducer of CYP1A proteins (Tanaka, et al., 1997) .
We found the PY74 metabolism by microsomal proteins from non-induced or phenobarbital-induced rat livers was considerably less than that from the 3MC-induced livers. This is consistent with our observations that CYP 1A1 and 1A2
were the isoforms responsible for PY74 metabolism because phenobarbital is an inducer primarily of CYP 2B's and to some extent 3A's (Martignoni et al., 2004) .
These data are consistent with the human CYP-specificity of PY74 metabolism where CYP1A1 and CYP1A2 had the highest activity of the tested CYP's for PY74 metabolism (Figure 5) . We found that PY74-M1 is also preferentially metabolized by CYP1A1 and 1A2 to its O-demethylated product (Figure 6 ).
These data suggest that tissue expressing CYP1A1 or CYP1A2 would have the capacity to metabolize PY74.
19
The skin is an important organ in the human body, not only serving as a barrier to the environment, but it also has the capacity to metabolize chemicals that enter the body by absorption through the skin. The skin does contain CYPs, albeit at low levels compared to other organs such as the liver and kidney (Mukhtar and Khan, 1989) . The CYPs in skin can be induced several-fold by a wide variety of substrates (Mukhtar and Bickers, 1981; Mukhtar and Khan, 1989) and are altered by exposure to ultraviolet light (Goerz et al., 1996) .
Janmohamed et al. (2001) have reported that mRNAs for CYP 2A6, 2B6, and 3A4 are expressed in human skin taken from surgical samples, and that these CYP's were primarily located in the epidermis, sebaceous glands, and hair follicles. Yengi et al. (2003) reported the presence of mRNA for CYP 1A1, 1B1, 2B6, 2C9, 2C18, 2C19, 2D6, 2E1, 3A4 and 3A5 in human skin, while CYP 1A2, 2A6, and 2C8 mRNA levels were below the detection limits of their assay. Ahmad et al. (1996) reported CYP 1A1 was the major CYP in rodent skin, which is consistent with reports of the induction of CYP activity in the skin of rodents treated with 3MC and other inducers of CYP 1A. Du et al. (2004 ) reported 13 cytochromes of the CYP2 family, including 2A6, 2A7, 2B6, 2C9, 2C18, 2C19, 2D6, 2E1, 2J2, 2R1, 2S1, 2U1, and 2W1, were present in human skin samples.
In summary, the skin contains many different CYPs, which have been detected as either mRNA, enzyme activities or protein levels.
Our work has shown that PY74 is metabolized by human CYP1A1, CYP1A2, 1B1, and 3A4. These CYPs are present in the skin of rodents and humans, suggesting that metabolism of PY74 could occur there in vivo.
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21 1991). Metabolic azoreduction and cleavage is believed to be an activation reaction since the reduction products of some azo compounds exhibit toxic and mutagenic effects (Chung, 1983; Martin and Kennelly, 1985) . A structure-activity study of various azobenzenes revealed that a polar electron-donating group (amino or hydroxyl) para to the azo linkage is required for substrate activity with
microsomes. An electron-withdrawing group, such as a nitro group, on the benzoyl moiety prevents electron donation to the azo ring system and the resulting product is inactive in azo reduction (Zbaida, 1995) . Although we did not examine the azoreduction of PY74 by skin microsomes or cytosol in our metabolic system, skin azoreduction of several azo compounds including ANSC have been demonstrated with a percutaneous absorption system (Collier et al., 1993) . Therefore, the potential for azoreduction of PY74 by skin does exist and should be investigated. In addition, simulated solar light (Cui et al., 2004) and laser light used for tattoo removal (Vasold et al., 2004) have been shown to photochemically cleave PY74 at the azo group to generate aromatic amines, such as 2-methoxy-4-nitroaniline and 2-aminoanisole from PY74.
Under the definitions given in the Food Drug and Cosmetic Act, and associated regulations in 21 US Code of Federal Regulations Title 21, tattoo inks have been categorized by the FDA to be professional use cosmetics. As a result, the pigments contained in the inks are considered to be color additives.
Both cosmetics and color additives fall under the regulatory authority of FDA.
This article has not been copyedited and formatted. The final version may differ from this version. Although individuals are encouraged to report adverse events resulting from FDA-regulated products to the US Food & Drug Administration, the lack of public perception that tattoo inks are regulated by the FDA probably explains why few complaints have been received, explaining why a comprehensive assessment or database on adverse events resulting from tattooing does not exist.
The results described in this paper show that tattoo ink pigments can be metabolized by phase I enzymes (CYPs) that exist in the skin of rodents and man. Anecdotal reports of tattoo fading are routinely heard from tattoo recipients who have yellow and orange tattoos. We suggest the mechanisms for fading could include: (1) dispersion through the skin; (2) phagocytosis and removal; (3) metabolism of the pigments in the skin (this report); (4) photochemical decomposition of the pigments as reported for PY74 (Cui et al., 2004; Vasold et al., 2004) . No reports exist regarding the mutagenic, carcinogenic, or photocarcinogenic potential of PY74; however, 2-aminoanisole (o-anisidine) can be enzymatically activated in vitro to form DNA adducts (Stiborova et al., 2001 (Stiborova et al., , 2002 and is a urinary bladder carcinogen in mice and rats (National Toxicology Program, 1978) . Oxidation of PY74-M1 could result in the formation of structure similar to a p-quinone imine, which is the active intermediate for o-anisidine (Stiborova et al., 2002) and acetaminophen (NAPQI; Rogers et al., 1997) . In order to conduct a risk assessment for PY74, further studies on the purity of PY74 used in tattoo inks, the in vivo metabolism of PY74 in the skin, and quantification of the toxicity of its metabolites are among some of the studies that are warranted.
